Get Ahead with IPO Insights, IPO Prophet

IPO Prophet

IPO Prophet® is a real-time IPO intelligence platform that gives investors a data-driven edge. Our team brings over 75 years of combined experience trading and investing in IPOs, translating firsthand market execution into proprietary quantitative analytics designed for today’s issuance environment.

Unlike traditional research providers that rely solely on commentary and retrospective analysis, IPO Prophet® is grounded in actual trading experience across multiple IPO cycles. Our platform integrates live market data, historical performance benchmarks, and predictive models to help investors evaluate deal quality, pricing discipline, demand strength, and post-IPO trading behavior as it unfolds.

From pre-deal analysis through pricing and aftermarket performance, IPO Prophet® delivers actionable, data-driven intelligence that helps investors make informed decisions at the moments that matter most.

Get Ahead with IPO Insights

At IPO Prophet®, our team leverages over three decades of expertise to deliver actionable quantitative analytics for the IPO market in real-time. This platform synthesizes our extensive experience investing in IPOs, providing investors with revolutionary tools to navigate the complexities of issuance day. Our mission is to empower investors with data-driven insights to make more informed decisions.

Equity Capital Markets

Odyssey Therapeutics / Equity Capital Markets

<ul><li>Odyssey Therapeutics (ODTX) and Mobia Medical (MOBI) both struggled to generate meaningful Day-One momentum Friday, with neither deal producing a Bull signal despite very different opening setups.</li><li>Odyssey opened at a premium to its $18 IPO price, trading as high as $20.30 shortly after the open, but the move lacked the type of sustained institutional follow through typically associated with stronger IPO debuts.</li><li>IPO Prophet’s posture on ODTX was initially neutral during the opening trade before sentiment shifted bearish early in the session as momentum deteriorated and shares steadily faded throughout the afternoon, ultimately closing at $16.42.</li></ul>

Odyssey Therapeutics (ODTX) and Mobia Medical (MOBI) both struggled to generate meaningful Day-One momentum Friday, with neither deal producing a Bull signal despite very different opening setups.Odyssey opened at a premium to its $18 IPO price, trading as high as $20.30 shortly after the open, but the move lacked the type of sustained institutional follow through typically associated with stronger IPO debuts.IPO Prophet’s posture on ODTX was initially neutral during the opening trade before sentiment shifted bearish early in the session as momentum deteriorated and shares steadily faded throughout the afternoon, ultimately closing at $16.42.

Blackstone Digital Infrastructure Trust (BXDC US)

IPO Market Sees Weak Day-One Follow Through as Odyssey Fades and Mobia Opens Under Pressure